Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates

被引:79
作者
Tavío, MD
Vila, J
Ruiz, J
Ruiz, J
Martín-Sánchez, AM
de Anta, MTJ
机构
[1] Univ Las Palmas Gran Canaria, Sch Med, Dept Clin Sci, Las Palmas Gran Canaria 35080, Spain
[2] Univ Barcelona, Sch Med, Dept Microbiol, Hosp Clin, E-08036 Barcelona, Spain
关键词
D O I
10.1093/jac/44.6.735
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83-->Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87-->Asn (n = 2). Only one concomitant mutation in parC(Ser-80-->Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required less than or equal to 1 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.
引用
收藏
页码:735 / 742
页数:8
相关论文
共 21 条
[1]  
[Anonymous], 1993, M7A3 NCCLS
[2]   Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV [J].
Breines, DM ;
Ouabdesselam, S ;
Ng, EY ;
Tankovic, J ;
Shah, S ;
Soussy, CJ ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :175-179
[3]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[4]   Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals [J].
Everett, MJ ;
Jin, YF ;
Ricci, V ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2380-2386
[5]   NOVEL QUINOLONE RESISTANCE MUTATIONS OF THE ESCHERICHIA-COLI DNA GYRASE A-PROTEIN - ENZYMATIC ANALYSIS OF THE MUTANT PROTEINS [J].
HALLETT, P ;
MAXWELL, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (02) :335-340
[6]   DIFFERENCES IN SUSCEPTIBILITY TO QUINOLONES OF OUTER-MEMBRANE MUTANTS OF SALMONELLA-TYPHIMURIUM AND ESCHERICHIA-COLI [J].
HIRAI, K ;
AOYAMA, H ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :535-538
[7]   ISOLATION AND CHARACTERIZATION OF NORFLOXACIN-RESISTANT MUTANTS OF ESCHERICHIA-COLI K-12 [J].
HIRAI, K ;
AOYAMA, H ;
SUZUE, S ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :248-253
[8]   MORPHOLOGICAL HETEROGENEITY AMONG SALMONELLA LIPOPOLYSACCHARIDE CHEMOTYPES IN SILVER-STAINED POLYACRYLAMIDE GELS [J].
HITCHCOCK, PJ ;
BROWN, TM .
JOURNAL OF BACTERIOLOGY, 1983, 154 (01) :269-277
[9]   GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF NORFLOXACIN RESISTANCE IN ESCHERICHIA-COLI [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
TUNG, C ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (04) :639-644
[10]   ACTIVE EFFLUX OF OFLOXACIN BY A HIGHLY QUINOLONE-RESISTANT STRAIN OF PROTEUS-VULGARIS [J].
ISHII, H ;
SATO, K ;
HOSHINO, K ;
SATO, M ;
YAMAGUCHI, A ;
SAWAI, T ;
OSADA, Y .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 (06) :827-836